Table 2.
Alpha diversity analysis of biliary microbiota in patients with dCCA and the onset of common bile duct stones.
| Sample | mean (group_T) | sd (group_T) | mean (group_C) | sd (group_C) | mean (group_P) | sd (group_P) | p value |
|---|---|---|---|---|---|---|---|
| Observed_OTU | 209.6250 | 74.5576 | 165.0682 | 90.5750 | 134.2500 | 66.9423 | 0.0976 |
| Chao | 243.4245 | 73.2746 | 202.2659 | 94.6487 | 181.1733 | 71.3074 | 0.2413 |
| Shannon | 2.8807 | 1.1989 | 1.9514 | 1.1148 | 1.8863 | 0.8409 | 0.0989 |
| Simpson | 0.7738 | 0.2312 | 0.6270 | 0.2620 | 0.6687 | 0.2271 | 0.2010 |
| Goodscoverage | 0.9986 | 0.0006 | 0.9983 | 0.0008 | 0.9983 | 0.0008 | 0.8360 |
| Shannoneven | 0.5355 | 0.2064 | 0.3794 | 0.1877 | 0.3874 | 0.1515 | 0.0887 |
OTU, operational taxonomic unit; sd, Standard Deviation. The dCCA group (Tumor group, T), the new onset of CBD stones group (CBD stones group, C), and recurrent CBD stones group (Post-ERCP CBD stones group, P) denoted as “Group T”, “Group C”, and “Group P”, respectively, in the table.